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 Introduction
Kobuvirus is a relatively recently described genus of the
ornaviridae family. Human Aichi virus (AiV), its ﬁrst
ember, was isolated from faecal samples of human
tients with oyster-associated nonbacterial gastroenter-
s in Japan in 1989 (Yamashita et al., 1991). Since then,
V has been detected in many countries around the world,
pecially in outbreaks associated with consumption of
sters and other shell-ﬁsh, and in sporadic disease in
ildren (Ambert-Balay et al., 2008; Kaikkonen et al., 2010;
 et al., 2006; Pham et al., 2007; Reuter et al., 2009; Sdiri-
ulizi et al., 2008; Yang et al., 2009). Other members of the
buvirus genus have now been described causing enteric
infections in cattle (Barry et al., 2011; Khamrin et al., 2008;
Park et al., 2011), pigs (Barry et al., 2011; Khamrin et al.,
2009; Reuter et al., 2008), wild boar (Reuter et al., 2012),
bats (Li et al., 2010), sheep (Reuter et al., 2010) and rodents
(Phan et al., 2011). Their role as a primary pathogen
remains uncertain (Kaikkonen et al., 2010; Lorrot et al.,
2011), and mixed infections are common (Ambert-Balay
et al., 2008). Although detection of AiV itself is rare,
seroprevalence of antibody to AiV is high in humans,
approaching 100% in adults, suggesting infection is
common (Ribes et al., 2010; Yamashita et al., 1993).
Human AiV has a linear, positive sense ssRNA genome
of 8270 nucleotides, and exists as non-enveloped, 22–
30 nm icosahedral particles (Yamashita et al., 2003). The
RNA molecule contains one large open reading frame
encoding a single polyprotein which like other members of
the Picornaviridae family is cleaved into structural and
non-structural proteins. Initially two genotypes of AiV
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A B S T R A C T
The kobuviruses represent an emerging genus in the Picornaviridae. Here we have used
next generation sequencing and conventional approaches to identify the ﬁrst canine
kobuvirus (CaKoV) from outside the USA. Phylogenetic analysis suggests that a single
lineage genotype of CaKoV now exists in Europe and the USA with 94% nucleotide
similarity in the coding region. CaKoV was only identiﬁed in a single case from a case–
control study of canine diarrhoea, suggesting this virus was not a frequent cause of disease
in this population. Attempts to grow CaKoV in cell culture failed. Sequence analysis
suggested CaKoV was distinct from human Aichi virus (AiV), and unlikely to pose a
signiﬁcant zoonotic risk. Serosurveys by ELISA, immunoﬂuorescence and neutralisation
tests, using AiV as antigen, suggested kobuvirus infection is prevalent in dogs. In addition,
IgG antibody to AiV was also detected in cat sera, indicating for the ﬁrst time that cats may
also be susceptible to kobuvirus infection.
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equence in the 3C–3D junction (Yamashita et al., 2000).
ore recently a third genotype type has been identiﬁed
mbert-Balay et al., 2008). Some unique molecular
atures have been described compared to other picorna-
iruses. Yamashita et al. (1998) showed that the VP0 capsid
rotein is expressed in the mature particle in Aichi virus
nd does not undergo cleavage (Yamashita et al., 1998) in
ontrast to other picornaviruses (Hellen and Wimmer,
992). Also the 2A and L protein of Aichi virus have no
rotease or autocatalytic motifs as documented for other
icornaviruses and their function remains unknown
amashita et al., 1998).
In dogs, the ﬁrst kobuviruses were described in 2011. In
 study of acute gastroenteritis in canine shelters in the
nited States, 5 of 18 dogs from two of three outbreaks
sted positive for kobuviruses. Sequence analysis and
istances from AiV genotypes A and B led the authors to
ropose these viruses be called canine kobuvirus (CaKoV)
apoor et al., 2011). In a separate study published around
e same time, a similar virus was detected in the stools of
ree dogs with diarrhoea (Li et al., 2011). Based on
equence analysis, the canine virus was independently
amed CaKoV and tentatively classiﬁed as a novel species,
losely related to AiV, in the genus Kobuvirus. Follow up
CRs of 200 sick and healthy dogs found CaKoV in 14
ealthy and six diarrhoeic dogs. Both of these studies failed
 identify a clear role for CaKoV in disease, suggesting that
ny pathogenicity was likely to be low, at least in the
ostly adult canine population they tested.
Here, we describe canine kobuvirus in the UK, and
rovide serological evidence for widespread kobuvirus
fection in cat and dog populations. The relationship of
ese carnivore viruses with AiV is discussed.
. Methods
.1. Samples
The faecal samples in this study were from an existing
ase–control study to determine the role of canine enteric
oronavirus (CECoV) and other potential pathogens in
nteric disease (Stavisky et al., 2011). As well as using PCR
 detect known pathogens, electron microscopy was also
onducted on all cases (N = 86) and on 60 controls. In two
ases and one control, myxovirus-like particles were
escribed. These samples tested negative using conven-
onal PCR for canine distemper and parainﬂuenza (data
ot presented). One of these samples (UK003) was from a
o month-old Staffordshire-bull terrier-cross that pre-
ented collapsed with diarrhoea and vomiting. This puppy
as also shedding type II CECoV and Campylobacter
psaliensis, as well as Toxacara canis and Toxacara leonina.
ample UK003 was used for next generation sequencing.
AiV strain A846/88 (genotype A), was isolated by
amashita et al. (1991), and kindly provided by Pierre
othier (University of Dijon, France). This strain was
ropagated in Vero cells, recovered from cell lysates, and
lariﬁed by centrifugation, and the supernatant was divided
to aliquots, which were stored at 80 8C. The stock virus
as titrated by immunoﬂuorescence on Vero cells.
Anonymized canine (N = 198) and feline (N = 97) serum
samples were obtained as part of routine diagnostic work
being carried out on animals attending the University of
Liverpool Small Animal Teaching Hospital. For conﬁdenti-
ality reasons, clinical data could not be obtained with the
samples.
2.2. Sample preparation, sequencing and informatics
Faecal samples were puriﬁed and nucleic acid extracted
essentially according to published protocols with minor
modiﬁcation (Finkbeiner et al., 2008; Wang et al., 2003).
Brieﬂy, chips of frozen archived faeces (30–150 mg) were
resuspended in 6 volumes of PBS, clariﬁed by centrifuga-
tion (9700  g, 10 min), and the supernatants passed
through 0.45 mm ﬁlters. RNA was extracted from 100 ml
of the ﬁltrate (Qiagen RNA extraction kit) without the
DNase step, reverse transcribed (Superscript) using primer
A (50-GTTTCCCAGTCACGATCNNNNNNNNN-30), and ampli-
ﬁed using primer B (50-GTTTCCCAGTCACGATC-30). Smears
of DNA were gel puriﬁed and submitted for library
preparation according to standard protocols.
Whole-genome shotgun pyrosequencing was per-
formed by generating a standard DNA fragment library
(Roche Applied Sciences, Indianapolis, IN) and sequenced
with a GS-FLX using Titanium chemistry (454 Life Sciences,
Roche Applied Sciences). The 454 reads were assembled
with Newbler (v2.3 Roche Applied Sciences), and results
compared to a viral protein database downloaded from
NCBI Jan 2009 using BlastX.
The full genome of UK003 was determined by sequen-
cing overlapping amplicons generated by multiple PCRs
using primers based on the draft next generation genome,
and 50/30 RACE. Maximum likelihood trees with 1000
bootstrap replicates were calculated using PHYML 3.0
(Guindon and Gascuel, 2003) using the most appropriate
model of evolution, which was identiﬁed using the model
selection approach implemented in Topali v2.5 (Milne
et al., 2009).
2.3. Viral prevalence by PCR detection
Based on the results of next generation sequencing, a
diagnostic PCR assay was designed to screen the case–
control study (80 cases and 147 controls) for the presence
of a putative Aichi/kobu viruses. RNA was extracted from
140 ml of virus transport medium containing the faecal
sample using the QIAamp viral RNA extraction kit (Qiagen),
and ﬁrst strand cDNA synthesis was carried out using the
RNA SuperscriptIII kit (Invitrogen), following the manu-
facturer’s instructions. Reactions contained 1 ml oligodT or
random hexamers, 3 ml RNA, 2 ml 5 mM dNTP mix, 8 ml
H2O, 4 ml ﬁrst-strand buffer, 1 ml 0.1 M DTT and 1 ml
SuperscriptIII. Reactions were incubated at 25 8C for 5 min,
50 8C for 60 min and 70 8C for 15 min. The resulting cDNA
was used as the template for the PCR assay.
Five separate oligonucleotide primers were designed
(three forward and two reverse), based on the known
sequences of three kobuviruses: AiV (AB010145), porcine
kobuvirus (EU787450) and our putative CaKoV. The
primers sequences were chosen to match our CaKoV
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N. Carmona-Vicente et al. / Veterinary Microbiology 164 (2013) 246–252248quence in regions of high similarity to the other
buviruses. The ﬁve primers were tested in all combina-
ns with the following conditions: initial denaturation
 8C for 5 min: 30 cycles of 30 s at 94 8C, 30 s at 55 8C, 30 s
 72 8C and a ﬁnal elongation step of 7 min at 72 8C, using
003 as positive control. The most successful combina-
n (DogF3; 50-CACCTACGACTGGGCCACGCTCC-30 and
gR2; 50-GTGGGGAAGGTAGAGAAGTAGAGGTC-30), hav-
g the clearest, brightest product was selected for use in
ture diagnostic PCR assays. These primers ampliﬁed
50 bases of kobuvirus RNA, equivalent to bases 6205–
61 of AiV AB010145 3CD region.
As well as this single stage PCR, a nested PCR was
veloped using DogF3 and DogR2, followed by primers
gF4 (50-GTCCACACCCCTACCTCCCGCC-30) and DogR1
0-CGTGTTTGAGGAAGAGTTGGGTGTC-30), using the
cling conditions described above.
. Cell culture
Brieﬂy, conﬂuent cell lines A72 [ATCC CRL-1542; p179–
2], MDCK [ATCC CCL-34; p156–166] and Vero cells
TCC CCL-81; p64–68] were grown in EMEM (Sigma) with
 FBS. Cells were inoculated with 100 ml of ﬁltered faecal
mple (from a pre wetted 0.2 ml ﬁlter). These samples had
en stored in virus transport medium or pooled brain
art infusion media and incubated for up to 7 days in
aintenance media. Samples were checked daily for
topathic effect (cpe) and compared to negative controls.
ch passage was frozen at 808C, thawed and repeated
ce.
Detection of speciﬁc antibodies against Aichi virus by
ISA: viral antigen was partially puriﬁed from AiV
notype A A846/88-infected cells by ultracentrifugation.
hen the cpe was 80–90%, the cell cultures were frozen
d thawed three times, and clariﬁed by low-speed
ntrifugation (15,450  g for 25 min). The supernatants
ere concentrated by ultracentrifugation at 50,000 rpm
r 2 h at 4 8C using a Beckman 70 Ti rotor. Pellets were
suspended in 300 ml of TNC (0.05 M Tris–HCl, 0.15 M
Cl, 0.01 M CaCl2). The protein concentration was
termined by the Bradford method (Bio-Rad) and the
ral antigen preparations stored at 80 8C.
Ninety-six-well polystyrene microtiter plates (Costar)
ere coated with 10 mg/well with partially puriﬁed
tigen diluted in 0.05 M carbonate/bicarbonate buffer
H 9.6), incubated for 2 h at 37 8C, and washed three times
ith 0.5% Tween 20 in phosphate buffered saline (PBS-T).
ates were incubated for 1.5 h at 37 8C with 100 ml
lutions of serum samples in PBS containing 1% bovine
rum albumin (PBS–BSA). Dilutions were 1:100 for
tibody screening or 100 ml of serially diluted serum
mples for antibody titration. After three washes with
S-T, 100 ml of horseradish peroxidase (HRP)-conjugated
ti-dog (or anti-cat) IgG antibody (Novus Biologicals)
luted 1:2000 in PBS–BSA were added to each well and
cubated at 37 8C for 1 h. The plates were washed four
es with PBS-T and bound antibody detected with 50 ml
 o-phenylenediamine (OPD), followed by incubation at
om temperature for 10 min. The reaction was stopped
ith 3 M H2SO4 and the absorbance was read at 492 nm
(Multiskan FC spectrophotometer, Thermo Scientiﬁc).
Since the semi-puriﬁed AiV preparation could contain
cellular debris, serum samples were tested simultaneously
against antigens of uninfected Vero cells extracted by the
same procedure. The absorbance value of each serum
sample against the cellular antigens was subtracted from
the absorbance value obtained against the viral antigen. A
pool of AiV-positive dog sera were used in follow up
experiments as positive controls, and three dog sera
known to have no antibodies to this virus were included as
the negative controls in every assay. The cut-off value was
calculated as the mean of the negative controls plus 3
times the standard deviations of all negative controls.
2.5. Immunoﬂuorescence assay (IFA)
A random selection of serum samples testing positive
and negative by ELISA were also analysed by IFA. Vero cells
were grown on round coverslips (Marienfeld GmbH & Co.,
KG) in 24-well plates (Costar) at a concentration suitable to
form a conﬂuent monolayer within 24 h. The cells were
infected with AiV genotype A A846/88 in MEM medium
and adsorption was performed at 37 8C for 1 h. The inocula
were removed, maintenance medium (MEM with 2% SBF)
was added and the infected cell cultures were incubated
24 h at 37 8C. The cells were washed with PBS, ﬁxed with
methanol:acetone for 15 min on ice, washed two further
times with PBS and incubated with dog/cat serum samples
diluted 1:100 in PBS containing 1% bovine serum albumin
(BSA) (Sigma) for 1 h at 37 8C. The coverslips were washed
three times with PBS and incubated with a ﬂuoresceine
isothiocyanate (FITC)-labelled rabbit serum anti-dog or
anti-cat IgG (Santa Cruz Biotechnology) for 1 h at 37 8C. The
monolayers were washed ﬁve times in PBS and stained
with Evans blue. Finally, the coverslips were mounted onto
glass slides with buffered glycerol (Light Diagnostics),
examined under a ﬂuorescence microscope and images
were captured using a Nikon Digital Sight DS-Fi1 camera.
2.6. Seroneutralisation assay
Four canine and four feline sera that showed high
antibody titres to AiV genotype A by ELISA were
inactivated for 30 min at 56 8C and serially diluted 4-fold
in minimal essential medium (MEM) (Gibco-BRL). All
dilutions were mixed with an AiV suspension containing
50–100 ﬂuorescent focus-forming units (ffu) for 1 h at
37 8C. These mixtures were then added in duplicate to Vero
cell monolayers growing in 96-well plates, and incubated
for 1 h at 37 8C. Viral inocula were removed and the cells
were further incubated for 8 h, before ﬁxing in methanol–
acetone. Viral antigens were detected by indirect immu-
noﬂuorescence. Brieﬂy, ﬁxed cell monolayers were rinsed
with PBS and incubated for 1 h at 37 8C with a hyper-
immune human serum against Aichi virus diluted 1:500 in
PBS–BSA. The cells were washed twice with PBS and
incubated for 1 h at 37 8C with a FITC-conjugated antibody
against human IgG (Sigma) diluted 1:2000 in PBS–BSA. The
cells were then washed three times with PBS and observed
under a Nikon Eclipse ﬂuorescence microscope E600. Aichi
virus antibody-negative and positive human sera were
in
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N. Carmona-Vicente et al. / Veterinary Microbiology 164 (2013) 246–252 249cluded as negative and positive controls, respectively.
eutralising antibody titres were considered the inverse of
e sample serum dilution that showed a >60% reduction
 AiV ffu compared to the control.
. Results
.1. Sequencing
The only novel viral sequences identiﬁed in these faecal
amples were related to Kobo virus, and were found in a
ingle sample UK003. The 454 assembly had a total length
f 7594 bp with a GC% of 58.4, and greater than 25-fold
overage.
The ﬁnal sequence of CaKoV UK003 was 8213
haracters in length, including a 612base 50NTR,
332base polyprotein excluding the STOP codon, and a
4430NTR. The coding nucleotide sequence was 94%
imilar to both published CaKoV sequences, and 78%
imilar to the published sequence for AiV strain A846/88
genotype A; Genbank AB010145). The GenBank acces-
ion number for the genome sequence of CaKoV UK003 is
C161964.
Maximum likelihood phylogeny based on a 459 bp
lignment of the 3C–3D region showed CaKoV UK003 to be
losely related to the two canine strains from the USA,
istinct from AiV genotypes A–C, and the mouse kobuvirus.
.2. Attempts to grow virus in cell culture
Attempts to grow virus from sample UK003, as well as
om a representative panel of other samples failed. No cpe
as observed in any of the samples, and RT-PCR on media
nd cells failed to identify viral genome.
.3. Viral prevalence by PCR
The only sample testing consistently positive for
obuvirus from the case control study was UK003. This
uggested the prevalence of CaKoV-like viruses was 1.25%
5%, 1 of 80: CI 0.1%–7.7%) for cases and 0% (95% CI 0.1–
.2%) for the 147 controls. Fifty-one samples screened by
ested PCR also tested negative (Fig. 1).
.4. Serology
Aichi virus-speciﬁc IgG antibodies were detected in 74
7.4%) out of 198 dog serum samples and in 67 (69.9%) of
7 cat serum samples. Titres of Aichi virus-speciﬁc
ntibody in dog and cat serum samples are shown in
ig. 2. The highest antibody titre detected was 1:2000,
hich was found in 4 dog sera and in 4 cat sera.
To conﬁrm that dog and cat sera contained IgG
ntibodies speciﬁcally reacting to AiV antigens, IFA was
erformed on AiV-infected Vero cells with canine and
line serum samples that previously tested positive and
egative by ELISA. A characteristic granular perinuclear
ytoplasmic ﬂuorescence was observed with positive dog
ig. 3B) and cat sera (Fig. 3D), consistent with the pattern
bserved with control positive human sera (Fig. 3A). There
discriminating positive and negative samples (results not
shown).
A neutralisation assay was performed on a subset of 4
dog and 4 cat sera with high antibody titres to AiV detected
by ELISA, to verify whether these sera also inhibited AiV
infection in Vero cells. All samples showed signiﬁcant viral
neutralising activity, but with no clear correlation to their
ELISA titres (Table 1). The results also showed that dog sera
had stronger neutralising activity than cat sera despite
having similar titres by ELISA.
4. Discussion
Kobuviruses represent a relatively new and emerging
genus of the Picornaviridae with members infecting both
humans and other animal species including cattle, pigs,
bats, sheep, rodents and dogs (Kapoor et al., 2011; Li et al.,
Fig. 1. Maximum likelihood phylogeny of sequence UK003, with
representative sequences of canine and murine kobuvirus, and the
three genotypes of human AiV, rooted to porcine kobuvirus. Branch
lengths are to scale except in the outgroup. Numbers at major nodes are
bootstraps out of 1000 replicates.
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ruses have been implicated in diarrhoeal disease but the
idence for a primary pathogenic role remains contro-
rsial. We report here the ﬁrst observation of kobuvirus in
e UK. The virus was discovered by next generation
quencing, a powerful tool for the detection of novel
ruses (Radford et al., 2012). Although actual infection
as rare in dogs with diarrhoea, the seroprevalence study
r AiV cross-reactive antibodies in dogs and cats showed
fection with kobuviruses to be common in both these
ecies.
Our analysis is the ﬁrst to compare sequences of CaKoV
tained in more than one country. The phylogenetic
alysis reported here suggests one clade of canine
buvirus is now present both in the USA (Kapoor et al.,
2011; Li et al., 2011) and Europe. The CaKoV lineage is
phylogenetically distinct from the three known AiV
genotypes, and also other published kobuviruses, probably
representing a single recent transfer into this species. Our
failure to grow the CaKoV in various cell culture systems, is
in contrast to AiV (Yamashita et al., 1991), and suggests
these two viruses are currently adapted to independent
niches, although clearly we cannot rule out the virus being
inactivated during storage. These results suggest CaKoV is
unlikely to pose a signiﬁcant zoonotic risk. That said, it is
clear that geography also plays a strong part in the human
kobuvirus phylogeny, and it will therefore be important to
sequence AiV strains from the UK, and/or canine strains
from other countries.
The low prevalence of virus we report by RT-PCR is in
broad agreement with that previously described for
CaKoV. Kapoor et al. (2011) found 5 of 18 dogs from
two of three outbreaks in the USA tested positive for
CaKoV. In a second study, PCRs of 200 sick and healthy dogs
found CaKoV in 14 healthy and six diarrhoeic dogs (Li et al.,
2011). Both studies concluded there was no clear link
between CaKoV infection and disease. These levels of
infection are similar for those reported for other kobu-
viruses in sporadic disease (Ambert-Balay et al., 2008), and
suggest these viruses either cause in apparent infection or
are an uncommon cause of sporadic clinical disease in the
general population.
In humans, AiV infection is most frequently reported in
children (Kaikkonen et al., 2010; Reuter et al., 2009; Sdiri-
Loulizi et al., 2009). In our case control study, the mean age
of cases and controls was 68 and 65 months respectively,
. 3. Immunoﬂuorescence assay of serum IgG antibodies against AiV on infected Vero cells. (A) Human serum at 1:400 dilution as the positive control; (B)
g serum sample diluted 1:100; (C) negative control with PBS; (D) cat serum at 1:100 dilution. Vero cells were infected with AiV and further incubated for
. After washing and ﬁxing the cells with methanol:acetone, they were incubated with each serum dilution, washed and IgG antibodies were detected
ing FITC-labelled appropriate secondary antibodies.
ble 1
ISA and neutralisation titres of antibodies to human Aichi virus in four
g sera and in four cat sera.
og serum
amples
ELISA titres Neutralisation
titres
-112 1:1000 1:4096
-114 1:2000 1:512
-159 1:1000 1:4096
-194 1:1000 1:512
at serum
samples
-46 1:2000 1:64
-71 1:2000 1:32
-64 1:2000 1:256
-77 1:2000 1:32
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N. Carmona-Vicente et al. / Veterinary Microbiology 164 (2013) 246–252 251ith few juvenile (<6 months) animals included. The
ample in our study that did test positive for CaKoV was
om a two month-old puppy that presented with severe
isease, collapsed with diarrhoea and vomiting. This
uppy was also shedding type II CECoV and C. upsaliensis,
s well as T. canis and T. leonina. Kobuviruses are frequently
und with other known pathogens such as canine
arvovirus in dogs (Li et al., 2011), and rota-, astro and
oroviruses in humans (Ambert-Balay et al., 2008; Sdiri-
oulizi et al., 2008). In further studies, it will be important
 assess CaKoV prevalence in a cohort of younger animals,
nd in association with mixed infections, to see whether
o-infection is associated with disease severity.
The results of our seroprevalence study in dogs and cats
uggest that high percentages of these animals contain IgG
ntibodies against AiV genotype A. In the initial screening
ssay at 1:100 dilution, 37.4% dog serum samples and 69.1%
at serum samples were positive, suggesting that infection
ith AiV-cross-reactive kobuviruses is quite common
mong these animals. In humans, studies in Japan (Yama-
hita et al., 1993), Germany (Oh et al., 2006), France (Goyer
t al., 2008), and Spain (Ribes et al., 2010) show that up to
0–95% of the population have antibodies to AiV when they
re 30–40 years old. It has also been reported that AiV
fection can affect all age groups (Drexler et al., 2011).
hether the high seroprevalence we report results from
ymptomatic or asymptomatic infection is unknown.
Our inability to replicate CaKoV in cell culture limited
ur choices for serological assays. Future serological assays
ould be based on cloned capsid antigens, but were beyond
e scope of this project. We therefore chose to screen
anine (and feline samples) for the prevalence of anti-
odies cross-reacting with human AiV genotype A. To our
nowledge, there is no published data on the serological
ross-reactivity between different members of the kobu-
irus genus, nor between members of distinct AiV
enotypes. Therefore the virological origin of the high
eroprevalence detected in this study cannot be clear. For
xample, it is not known whether these seropositive
nimals represent kobuvirus infections that serologically
ross-react with genotype A AiV, or whether they indeed
epresent previous AiV infections. Although published data
enerally suggests kobuviruses are host speciﬁc, some
ross-species infections have been detected among farm
nimals (Khamrin et al., 2010; Park et al., 2011; Reuter
t al., 2011), and clearly the lifestyle of some pet dogs and
ats would provide opportunity for viral transmission
etween species (Chomel and Sun, 2011).
This is the ﬁrst paper to report possible kobuvirus
fections in cats, although clearly we cannot deﬁnitely say
ur assay is not cross-reacting with other feline picorna-
iruses (Lau et al., 2012). Clearly the identity of the virus or
iruses responsible needs to be determined, along with
eir relationship to AiV and CaKoV. There are now many
xamples of possible transmission of various microbiolo-
ical agents between these species (Clegg et al., 2012;
awson et al., 2000; Radford et al., 2007), perhaps
uggesting CaKoV might also be common to both the cat
nd the dog. It will clearly be important to assess the role of
obuviruses in feline disease, and also as a source of
5. Conclusion
In conclusion, we have demonstrated the presence of a
single clade of CaKoV in dogs in Europe and the USA.
Evidence for a role for the virus in disease in this species is
lacking, although high seroprevalence in both dogs and
cats suggests infection is common. In future studies it will
be important to clarify the serological cross-reactivity
between the members of this emerging picornavirus
genus, and the genetic relatedness of animal and human
kobuviruses from similar geographic regions, to rule out
any potential for zoonosis.
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